|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, technical, general and administrative | |||||
| Research and development | |||||
| Goodwill impairment | |||||
| Total operating expenses | |||||
| Operating profit | |||||
| Other (expense) income: | |||||
| Interest expense, net | |||||
| Foreign exchange (losses) gains | |||||
| Other expense, net | |||||
| Gain on divestitures | |||||
| Total other expense | |||||
| Income before income taxes and non-controlling interests | |||||
| Income tax expense | |||||
| Net income from continuing operations | |||||
| Income from discontinued operations, net of tax | |||||
| Net income | |||||
| Net income attributable to the non-controlling interests | |||||
| Net income attributable to common stockholders | |||||
| Earnings per share | |||||
| Basic from continuing operations (in dollars per share) | |||||
| Basic from discontinued operations (in dollars per share) | |||||
| Basic attributable to common stockholders (in dollars per share) | |||||
| Diluted from continuing operations (in dollars per share) | |||||
| Diluted from discontinued operations (in dollars per share) | |||||
| Diluted attributable to common stockholders (in dollars per share) | |||||
| Weighted average common shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...